Zacks Equity Research raised its guidance on Dallas-based Tenet Healthcare to "hold," the Ledger Gazette reports.
Here's what you should know.
1. Zacks raised its guidance based on Tenet's increased 2018 guidance. Although the company has an alarming amount of uncollectible accounts, contributing to mounting bad debt, Tenet has begun streamlining its core operations and adopted an enterprisewide, cost-reducing program.
2. The market's consensus rating is "hold." Three analysts assigned a "sell" rating, nine a "hold" rating and seven a "buy" rating.
3. Analysts assigned an average price target of $20.56 per share.